The increase in steatosis, increased expression of CD36, SREBF1, and SCD1, and the decreased expression of CEACAM1 and GLUT2 are all key features also seen in our hyperglycemic HepG2 model as well as the Leprdb/J mouse model. The gene discussed is SLC2A2; the disease is steatosis.